Founded in 2024, Eye Science (quarterly, ISSN 3005-9984, e-ISSN: 3005-9992; CN 44-1764/R) is a medical scholarly journal. It is governed by the Ministry of Education of the People's Republic of China, sponsored by Sun Yat-sen University, and published by the Zhongshan Ophthalmic Center, Sun Yat-sen University. Professor Haotian Lin from the Zhongshan Ophthalmic Center, Sun Yat-sen University holds the position of Editor-in-Chief, and Professor Zhenzhen Liu serves as the Executive Editor-in-Chief.
Eye Science has been selected for the "Excellence Action Plan of China's STM Journals - High-Starting Point New Journal Project" of China Association for Science & Technology (CAST). It compiles cutting-edge ophthalmological research from around the world, thereby establishing a platform for leading international academic exchange. Furthermore, it serves as the official journal of the Asia-Africa Council of Ophthalmology (AACO), an international medical academic organization.
About the Publisher:
Zhongshan Ophthalmic Center, Sun Yat-sen University is the only specialized ophthalmic hospital directly managed by the National Health Commission of China. It serves as the affiliated institution of the only National Key Laboratory for Ophthalmological Disease Prevention and Control. The Center is a national leader in ophthalmological innovation, making globally recognized contributions in areas such as regenerative ophthalmic medicine, bioinformatics, and medical artificial intelligence. Notably, the Center pioneered the in-situ regeneration of the lens using endogenous stem cells, a breakthrough published in Nature in 2016 and recognized by Nature Medicine as one of the "Top Eight Global Medical Advances" of the year, the first such honor for China's medical community. The research on myopia in adolescents received significant attention from President Jinping Xi, who issued an important directive in response. The Center's discovery that increased outdoor activities can effectively prevent myopia in adolescents was published in JAMA and has been incorporated into myopia prevention programs by both the World Health Organization (WHO) and Chinese government ministries. In addition, the Center has innovated in clinical applications of ophthalmic AI and successfully developed a new cataract drug, achieving a record-breaking technology transfer deal worth CNY 1.38 billion. The Center has won 11 National Science and Technology Progress Awards as the leading institution.
Zhongshan Ophthalmic Center is the most internationally influential ophthalmic institution in China. It is the only WHO collaborating center for ophthalmology in China and hosts the Asia-Pacific Academy of Ophthalmology, marking the first international medical academic organization based in Mainland China. The Center is also a member of ophthalmic research alliances in China, the UK, and the US.
Indexing:
CAS Content Collection
China Open Access Journals Database (COAJ)
CQVIP Database
Changjiang Library
Manuscript Processing Timeline:
- Initial Review: 3 days
- Peer Review: 2 weeks
- Online Publication: Within 1-week post-acceptance
- Formal Publication: Between 1 to 3 months post-acceptance, with original research articles receiving publication priority